Primary outcome measures | Secondary outcome measures |
---|---|
Serum cholesterol | BMI (Body Mass Index) |
Blood pressure (assessed according to British Hypertension Society Guidelines) | Self-reported diet |
Exercise capacity as assessed by the shuttle-walk test (the association with VO2 max has been validated in patients with heart failure and following CABG [76]) | Self-reported exercise (Godin[77]) |
Psychological morbidity: Hospital Anxiety and Depression Scale[78] (Asian patients will complete a translated version) | Health care utilisation (primary and secondary care and phase IV rehabilitation) |
Cotinine validated smoking cessation | Cardiac symptoms (angina and shortness of breath) |
 | Use of secondary preventive medication |
Adherence | Quality of life (Euroqol EQ5D) |
Self-reported physical activity at 6, 9 and 12 weeks | Death and cardiac events |
 | The Global Mood Scale to English speaking patients (at 6 months only) |
 | Quality of life (Short Form-12) (at 6 months only) |
 | Patient satisfaction with the programmes (at 6 months only) |